Dishman Carbogen Amcis Limited

Dishman Carbogen Amcis Limited (DCAL) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

imdcal.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-09-02

Stock price
₹176.85
Market cap
2,774 Cr
P/B
0.41

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales587 Cr651 Cr655 Cr524 Cr789 Cr682 Cr716 Cr708 Cr653 Cr720 Cr851 Cr678 Cr
Operating expenses (approx.)526 Cr610 Cr592 Cr495 Cr642 Cr542 Cr564 Cr567 Cr504 Cr607 Cr688 Cr618 Cr
EBITDA61 Cr41 Cr63 Cr29 Cr147 Cr140 Cr153 Cr141 Cr149 Cr113 Cr163 Cr60 Cr
OPM %10.4%6.3%9.6%5.5%18.6%20.5%21.3%19.9%22.8%15.7%19.1%8.9%
Other income8 Cr6 Cr7 Cr1 Cr7 Cr6 Cr8 Cr25 Cr8 Cr7 Cr16 Cr18 Cr
Interest27 Cr33 Cr31 Cr32 Cr37 Cr49 Cr42 Cr43 Cr42 Cr46 Cr43 Cr37 Cr
Depreciation75 Cr80 Cr85 Cr71 Cr72 Cr72 Cr79 Cr81 Cr84 Cr84 Cr89 Cr91 Cr
Profit before tax-36 Cr-66 Cr-49 Cr-78 Cr42 Cr27 Cr28 Cr39 Cr31 Cr-10 Cr46 Cr-51 Cr
Tax %-12.8%10.0%-42.1%-0.0%21.4%82.9%-55.6%39.5%-113.7%-24.2%52.9%-13.0%
Net profit-41 Cr-60 Cr-70 Cr-78 Cr33 Cr5 Cr43 Cr23 Cr65 Cr-13 Cr22 Cr-58 Cr
EPS (₹)₹-2.61₹-3.80₹-4.46₹-4.95₹2.11₹0.30₹2.75₹1.49₹4.16₹-0.83₹1.39₹-3.69

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales2,059 Cr2,044 Cr1,912 Cr2,141 Cr2,413 Cr2,616 Cr2,712 Cr2,932 CrSign in for TTM
Operating expenses (approx.)1,507 Cr1,521 Cr1,638 Cr1,809 Cr2,081 Cr2,329 Cr2,243 Cr2,366 CrSign in for TTM
EBITDA552 Cr522 Cr274 Cr331 Cr332 Cr287 Cr469 Cr566 CrSign in for TTM
OPM %26.8%25.6%14.3%15.5%13.8%11.0%17.3%19.3%Sign in for TTM
Other income54 Cr44 Cr38 Cr43 Cr28 Cr28 Cr22 Cr56 CrSign in for TTM
Interest57 Cr62 Cr48 Cr57 Cr86 Cr120 Cr159 Cr174 CrSign in for TTM
Depreciation240 Cr283 Cr308 Cr308 Cr281 Cr311 Cr294 Cr339 CrSign in for TTM
Profit before tax309 Cr222 Cr-65 Cr-4 Cr-55 Cr-122 Cr19 Cr105 CrSign in for TTM
Tax %31.9%18.8%-153.9%523.8%45.4%-25.5%83.2%7.1%Sign in for TTM
Net profit210 Cr180 Cr-165 Cr18 Cr-30 Cr-153 Cr3 Cr97 CrSign in for TTM
EPS (₹)₹13.03₹11.20₹-10.53₹1.15₹-1.90₹-9.79₹0.21₹6.22Sign in for TTM
Dividend payout %———0.0%——0.0%0.0%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital32 Cr31 Cr31 Cr31 Cr31 Cr31 Cr31 Cr31 Cr
Reserves5,347 Cr5,706 Cr5,667 Cr5,518 Cr5,778 Cr5,596 Cr5,800 Cr6,646 Cr
Borrowings883 Cr930 Cr1,046 Cr1,421 Cr1,825 Cr1,964 Cr2,084 Cr2,775 Cr
Other liabilities1,067 Cr1,555 Cr1,579 Cr1,668 Cr1,819 Cr1,990 Cr2,084 Cr2,471 Cr
Total liabilities7,328 Cr8,222 Cr8,325 Cr8,637 Cr9,454 Cr9,581 Cr9,999 Cr11,923 Cr
Fixed assets (net)1,533 Cr1,712 Cr1,699 Cr1,743 Cr1,961 Cr2,459 Cr2,684 Cr2,942 Cr
CWIP143 Cr202 Cr425 Cr755 Cr996 Cr501 Cr252 Cr275 Cr
Investments172 Cr196 Cr207 Cr329 Cr254 Cr106 Cr102 Cr96 Cr
Loans & advances4 Cr6 Cr4 Cr43 Cr3 Cr3 Cr4 Cr3 Cr
Inventories549 Cr607 Cr516 Cr645 Cr804 Cr883 Cr900 Cr1,019 Cr
Trade receivables445 Cr577 Cr379 Cr473 Cr590 Cr461 Cr665 Cr673 Cr
Cash & bank76 Cr122 Cr244 Cr110 Cr132 Cr264 Cr341 Cr788 Cr
Other assets4,405 Cr4,800 Cr4,852 Cr4,539 Cr4,714 Cr4,904 Cr5,052 Cr6,127 Cr
Total assets7,328 Cr8,222 Cr8,325 Cr8,637 Cr9,454 Cr9,581 Cr9,999 Cr11,923 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity———355 Cr220 Cr384 Cr375 Cr491 Cr
Cash from investing———-619 Cr-448 Cr-230 Cr-192 Cr-245 Cr
Cash from financing———130 Cr250 Cr-22 Cr-102 Cr201 Cr
Net cash flow———-133 Cr22 Cr264 Cr77 Cr447 Cr
Free cash flow (OCF − Capex)———-109 Cr-354 Cr81 Cr158 Cr225 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %5.8%4.3%-0.3%0.9%0.4%-0.0%2.3%3.0%
ROE %3.9%3.3%-2.9%0.3%-0.5%-2.7%0.1%1.5%
Debtor days79103728089648984
Inventory days528477445510468536553760
Days payable187223141153128148142158
Cash conversion cycle420357376438429452500686
Debt / equity0.000.160.000.260.310.350.360.42
Current ratio1.381.221.421.301.070.751.141.23
Net debt / EBITDA0.000.000.000.005.105.933.723.51

Compare with peers

Loading peers…